Insider trading

Period: 120 months Stock: CRNX + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

150 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

150 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

150 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

150 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
150 decisions over 120 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
150 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

150 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
28 Mar 2024
Okey Stephanie Director
Sold at will
$811.65K 17,500 at 46.38
74.5%
Sold half or more
22 Mar 2024
Knight Jeff E. Chief Operating Officer
Sold at will 2×
$1.43M 32,359 at 44.31
38.1%
Not planned
20 Mar 2024
Fust Matthew K Director
Sold on a plan 4×
$2.65M 60,000 at 44.14
76.4%
Sold half or more
20 Mar 2024
Pizzuti Dana Chief Med and Dev Officer
Sold at will 3×
$664.76K 15,089 at 44.06
35.2%
Not planned
19 Mar 2024
Sold on a plan
$297.88K 6,942 at 42.91
5.9%
Planned (10b5-1)
25 Jan 2024
Betz Stephen F. Chief Scientific Officer
Sold on a plan
$111.78K 3,000 at 37.26
3.9%
Planned (10b5-1)
10 Jan 2024
Betz Stephen F. Chief Scientific Officer
Sold on a plan
$112.95K 3,000 at 37.65
3.8%
Planned (10b5-1)
3 Jan 2024
Pizzuti Dana Chief Med and Dev Officer
Sold on a plan
$503.13K 14,375 at 35.00
70.9%
Sold half or more
2 Jan 2024
Sold on a plan
$354.70K 10,000 at 35.47
9.4%
Planned (10b5-1)
26 Dec 2023
Betz Stephen F. Chief Scientific Officer
Sold on a plan
$107.67K 3,000 at 35.89
3.6%
Planned (10b5-1)
21 Dec 2023
Pizzuti Dana Chief Med and Dev Officer
Sold at will
$331.28K 9,583 at 34.57
61.8%
Sold half or more
11 Dec 2023
Betz Stephen F. Chief Scientific Officer
Sold on a plan
$98.61K 3,000 at 32.87
3.5%
Planned (10b5-1)
27 Nov 2023
Betz Stephen F. Chief Scientific Officer
Sold on a plan
$95.52K 3,000 at 31.84
3.4%
Planned (10b5-1)
3 Nov 2023
Struthers Richard Scott President & CEO
Sold on a plan
$6.08M 199,082 at 30.56
59.5%
Sold half or more
2 Nov 2023
Struthers Richard Scott President & CEO
Sold on a plan
$27.49K 918 at 29.95
0.7%
Planned (10b5-1)
1 Nov 2023
Sold on a plan
$287.50K 10,000 at 28.75
9.5%
Planned (10b5-1)
17 Oct 2023
Krasner Alan Seth Chief Medical Officer
Sold on a plan
$210.00K 7,000 at 30.00
13.9%
Planned (10b5-1)
13 Jul 2023
Struthers Richard Scott President & CEO · indirect
Sold on a plan
$288.09K 14,157 at 20.35
2.2%
Planned (10b5-1)
12 Jul 2023
Struthers Richard Scott President & CEO · indirect
Sold on a plan
$231.13K 11,459 at 20.17
1.7%
Planned (10b5-1)
11 Jul 2023
Struthers Richard Scott President & CEO · indirect
Sold on a plan
$491.09K 24,384 at 20.14
3.6%
Planned (10b5-1)
20 Jun 2023
Sold on a plan 2×
$617.40K 30,922 at 19.97
24.5%
Planned (10b5-1)
16 Jun 2023
Struthers Richard Scott President & CEO · indirect
Sold on a plan
$1.04M 50,000 at 20.81
6.8%
Planned (10b5-1)
8 Jun 2023
Bought
$110.30K 5,000 at 22.06
opened
First buy on file
5 Apr 2023
Pizzuti Dana Chief Development Officer
Sold on a plan
$132.62K 8,212 at 16.15
64.6%
Sold half or more
1 Feb 2023
Betz Stephen F. Chief Scientific Officer
Sold, plan not stated
$61.24K 3,126 at 19.59
4.6%
25 Jan 2023
Betz Stephen F. Chief Scientific Officer
Sold, plan not stated
$175.64K 8,336 at 21.07
10.9%
17 Jan 2023
Betz Stephen F. Chief Scientific Officer
Sold, plan not stated
$56.27K 3,126 at 18.00
3.9%
3 Jan 2023
Betz Stephen F. Chief Scientific Officer
Sold, plan not stated
$57.36K 3,126 at 18.35
3.8%
15 Dec 2022
Betz Stephen F. Chief Scientific Officer
Sold, plan not stated
$50.02K 3,126 at 16.00
3.7%
1 Dec 2022
Betz Stephen F. Chief Scientific Officer
Sold, plan not stated
$55.77K 3,126 at 17.84
3.5%
15 Nov 2022
Betz Stephen F. Chief Scientific Officer
Sold, plan not stated
$58.52K 3,126 at 18.72
3.4%
1 Nov 2022
Betz Stephen F. Chief Scientific Officer
Sold, plan not stated
$57.89K 3,126 at 18.52
3.3%
17 Oct 2022
Betz Stephen F. Chief Scientific Officer
Sold, plan not stated
$55.42K 3,126 at 17.73
3.2%
3 Oct 2022
Betz Stephen F. Chief Scientific Officer
Sold, plan not stated
$61.39K 3,126 at 19.64
3.1%
15 Sep 2022
Betz Stephen F. Chief Scientific Officer
Sold, plan not stated
$87.57K 4,168 at 21.01
4.0%
7 Sep 2022
Betz Stephen F. Chief Scientific Officer
Sold, plan not stated
$21.88K 1,042 at 21.00
1.0%
1 Sep 2022
Betz Stephen F. Chief Scientific Officer
Sold, plan not stated
$58.11K 3,126 at 18.59
2.9%
26 Jul 2022
Knight Jeff E. Chief Operating Officer
Sold, plan not stated
$23.85K 1,152 at 20.70
18.9%
13 Jul 2022
Fust Matthew K Director
Sold, plan not stated
$119.45K 5,700 at 20.96
31.3%
2 May 2022
Betz Stephen F. Chief Scientific Officer
Sold, plan not stated
$65.25K 3,247 at 20.10
2.9%
18 Apr 2022
PERCEPTIVE ADVISORS LLC 10% owner · indirect
Bought
$3.50M 157,515 at 22.22
3.1%
18 Apr 2022
Betz Stephen F. Chief Scientific Officer
Sold, plan not stated
$146.19K 5,664 at 25.81
4.9%
13 Apr 2022
Struthers Richard Scott President & CEO · indirect
Sold, plan not stated 3×
$3.72M 138,643 at 26.83
15.9%
5 Apr 2022
Struthers Richard Scott President & CEO · indirect
Sold, plan not stated
$541.22K 21,357 at 25.34
2.4%
4 Apr 2022
Betz Stephen F. Chief Scientific Officer
Sold, plan not stated
$215.76K 9,000 at 23.97
7.2%
1 Apr 2022
Betz Stephen F. Chief Scientific Officer
Sold, plan not stated
$90.78K 4,164 at 21.80
3.2%
31 Mar 2022
Betz Stephen F. Chief Scientific Officer
Sold, plan not stated
$87.70K 4,164 at 21.06
3.1%
15 Mar 2022
Betz Stephen F. Chief Scientific Officer
Sold, plan not stated
$59.15K 3,123 at 18.94
2.3%
1 Mar 2022
Madan Ajay Chief Development Officer
Bought
$178.92K 9,000 at 19.88
5.4%
First buy on file
1 Mar 2022
Betz Stephen F. Chief Scientific Officer
Sold, plan not stated
$61.62K 3,123 at 19.73
2.2%
Showing 51–100 of 150. ← Newer Page 2 of 3 Older →